ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,628Medicare Part D Prescriptions Filled, Including Refills
$233K Total Retail Price of All Prescriptions
291 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
AMLODIPINE BESYLATE 281 241
OMEPRAZOLE 259 184
HYDROCHLOROTHIAZIDE 258 205
LEVOTHYROXINE SODIUM 218 162
SIMVASTATIN 213 171
FUROSEMIDE 188 157
LISINOPRIL 165 123
METOPROLOL SUCCINATE 159 142
DONEPEZIL HCL 147 144
PRAVASTATIN SODIUM 119 105
TRAMADOL HCL 112 91
NAMENDA 107 106
METFORMIN HCL 107 69
GABAPENTIN 106 93
ATORVASTATIN CALCIUM 104 94
METOPROLOL TARTRATE 98 90
MIRTAZAPINE 98 83
POLYETHYLENE GLYCOL 3350 89 51
FOSINOPRIL SODIUM 79 53
METFORMIN HCL ER 77 60
PANTOPRAZOLE SODIUM 75 54
SERTRALINE HCL 70 63
CARVEDILOL 68 60
POTASSIUM CHLORIDE 67 47
TRAZODONE HCL 65 47
ESCITALOPRAM OXALATE 59 53
FLUTICASONE PROPIONATE 58 27
HYDROCODONE-ACETAMINOPHEN 54 42 S3
LANTUS SOLOSTAR 54 33
HYDRALAZINE HCL 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.